These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16114743)

  • 1. Depo-Provera: new concerns--same issues?
    Robinson K
    AWHONN Lifelines; 2005; 9(3):214-7. PubMed ID: 16114743
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone loss in adolescents using Depo-Provera.
    Kass-Wolff JH
    J Soc Pediatr Nurs; 2001; 6(1):21-31. PubMed ID: 11288500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depo-Provera and bone density.
    Gbolade BA
    J Fam Plann Reprod Health Care; 2002 Jan; 28(1):7-11; quiz 11, 50. PubMed ID: 16259806
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA, contraceptive marketing approval and products liability litigation: Depo-Provera and the risk of osteoporosis.
    Green W
    Food Drug Law J; 2013; 68(2):115-35, i. PubMed ID: 24640465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depo-Provera--ethical issues in its testing and distribution.
    Potts M; Paxman JM
    J Med Ethics; 1984 Mar; 10(1):9-20. PubMed ID: 6231379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depo-Provera dilemmas.
    Cayley J
    Br J Fam Plann; 1998 Apr; 24(1):1. PubMed ID: 9719699
    [No Abstract]   [Full Text] [Related]  

  • 7. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.
    Wooltorton E
    CMAJ; 2005 Mar; 172(6):746. PubMed ID: 15743913
    [No Abstract]   [Full Text] [Related]  

  • 8. Depo Provera and bone density.
    Szarewski A; Mansour D; Hollingworth BA
    J Fam Plann Reprod Health Care; 2002 Apr; 28(2):94. PubMed ID: 12422861
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of DMPA by adolescents.
    Gold MA; Hertweck SP; Lara-Torre E
    J Pediatr Adolesc Gynecol; 2005 Dec; 18(6):435-7. PubMed ID: 16338614
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug regulation in the United States and the United Kingdom: the Depo-Provera story.
    Richard BW; Lasagna L
    Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Sep; 112(3):727-30. PubMed ID: 18757687
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera).
    Cromer BA
    Curr Opin Obstet Gynecol; 1999 Oct; 11(5):467-71. PubMed ID: 10526923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M; Liblanc M
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depo-Provera and skeletal health: reviewing the evidence; developing and disseminating a consensus.
    Guilbert ER; Kaunitz AM
    Contraception; 2009 Mar; 79(3):165-6. PubMed ID: 19185667
    [No Abstract]   [Full Text] [Related]  

  • 17. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case for concern?
    Gartland A
    Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive use in teens: a threat to bone health?
    Gold MA; Bachrach LK
    J Adolesc Health; 2004 Dec; 35(6):427-9. PubMed ID: 15581517
    [No Abstract]   [Full Text] [Related]  

  • 20. Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians.
    Paschall S; Kaunitz AM
    Contraception; 2008 Nov; 78(5):370-6. PubMed ID: 18929733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.